Clinical Trial: Comparison of the Pharmacokinetic (PK) and Pharmacodynamic (PD) Biosimilarity of Insulin Aspart 30 Injections After Single-Dose Subcutaneous Administration to Healthy Volunteers

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07875803) titled 'Comparison of the Pharmacokinetic (PK) and Pharmacodynamic (PD) Biosimilarity of Insulin Aspart 30 Injections After Single-Dose Subcutaneous Administration to Healthy Volunteers' on Oct. 08.

Brief Summary: The present study is designed to compare the pharmacokinetic, pharmacodynamic and safety characteristics of UBLIN 30(R) (test product) and NovoMix(R)30 (reference product) in healthy male participants. The treatment consists of one single dose of the test or reference product, administered during each of the two study periods, separated by 7 days between dosing. A total of 52 participants will be enrolled in this trial and randomi...